CD274 and non-small cell lung carcinoma: Although several reports demonstrate associations between the GPS and therapeutic effects of ICIs in patients with NSCLC with different treatment lines and various ICIs and levels of PD‐L1 expression,9, 20, 21 no significant differences between GPSs of 0–1 and 2 were observed in terms of PFS and OS in the current study.